Publications by authors named "Jesse Chow"

Claim this Profile
A
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.
Manav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, Roland Seiler, Craig Furman, Jesse Chow

Nat Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.
Manav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, Roland Seiler, Craig Furman, Jesse Chow

Nat Commun· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells.
Zoltán Dezső, Judith Oestreicher, Amy Weaver, Stephanie Santiago, Sergei Agoulnik, Jesse Chow

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo.
Marc Lamphier, Wanjun Zheng, Eicke Latz, Mark Spyvee, Hans Hansen, Jesse Chow

Mol Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin mesylate exerts specific gene expression changes in pericytes and shortens pericyte-driven capillary network in vitro.
Sergei I Agoulnik, Satoshi Kawano, Noel Taylor, Judith Oestreicher, Junji Matsui, Jesse Chow

Vasc Cell· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Prasad Rallabhandi, Rachel L Phillips, Marina S Boukhvalova, Lioubov M Pletneva, Kari Ann Shirey, Jesse C Chow

mBio· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E6201 [(3S,4R,5Z,8S,9S,11E)-14-(ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-1 and MEK kinase-1: in vitro characterization of its anti-inflammatory and antihyperproliferative activities.
Masaki Goto, Jesse Chow, Kenzo Muramoto, Ken-ichi Chiba, Satoshi Yamamoto

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.
Elena von Schlieffen, Olga V Oskolkova, Gernot Schabbauer, Florian Gruber, Stephan Blüml, Jesse Chow

Arterioscler Thromb Vasc Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 2 antagonists. Part 1: preliminary SAR investigation of novel synthetic phospholipids.
Mark R Spyvee, Huiming Zhang, Lynn D Hawkins, Jesse C Chow

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Maureen Mullarkey, Jeffrey R Rose, John Bristol, Tsutomu Kawata, Akufumi Kimura, Jesse Chow

J Pharmacol Exp Ther· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.
Melinda Przetak, Jesse Chow, Hongsheng Cheng, Jeffrey Rose, Lynn D Hawkins

Vaccine· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.
Lynn D Hawkins, Sally T Ishizaka, Pamela McGuinness, Huiming Zhang, Wendy Gavin, Jesse C Chow

J Pharmacol Exp Ther· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis